Déclaration internationale en faveur de la recherche et du développement de médicaments pour le traitement de l'EM/SFC et du COVID long
- Millions Missing Belgique
- il y a 2 heures
- 3 min de lecture
Cette déclaration pose le constat des manques de reconnaissance, de financements pour la recherche, d'éducation médicale et appelle à 5 mesures concrètes pour sortir de l'inaction:
- Défi et responsabilité mondiaux,
- Financement et infrastructure,
- Recherche et essais biomédicaux,
- Partenariat avec les patients,
- Éducation et sensibilisation.
Malheureusement, mais sans grande surprise, nous notons l'absence de médecins et/ou chercheur-ses belges.
L'intégralité dela déclaration peut être trouvée ici:
Signataires
- Ziyad Al-Aly, Prof (MD), Washington University in St. Louis, USA
- Anna Aschenbrenner, Dr (PhD), German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany
- Nina Babel, Prof (MD), Charité – Universitätsmedizin Berlin, Germany
- Lucinda Bateman, Dr (MD), Bateman Horne Center Salt Lake City, Utah, USA
- Uta Behrends, Prof (MD), Technical University of Munich (TUM) Hospital and Munich Schwabing Clinic, Germany
- Judith Bellmann-Strobl, Dr (MD), Charité - University Medicine Berlin, Germany
- Jonas Bergquist, Prof (MD, PhD), Biomedical Centre, Uppsala University, Sweden
- Michelle Bull, Dr, Physios for ME, UK
- Oliver Cornely, Prof (MD), Uniklinik Köln, Germany
- Jeroen den Dunnen, Prof (PhD), Amsterdam University Medical Center (UMC), Netherlands
- Meike Dirks, Dr (MD), Hannover Medical School (MHH), Germany
- Wesley Ely, Prof (MD), MPH, Vanderbilt University Medical Center, USA
- Øystein Fluge, Prof (MD), University of Bergen, Norway
- Patricia Grabowski, Dr (MD), Charité – Universitätsmedizin Berlin, Germany
- Bettina Grande, Charité - Universitätsmedizin Berlin, Germany
Tilman Grande, Dr, Charité- Universitätsmedizin Berlin, Germany
- Kathryn Hoffmann, Prof (MD), MPH, Medical University of Vienna, Austria
- Brian Hughes, Prof (PhD), University of Galway, Ireland
- Akiko Iwasaki, Prof (PhD), Yale University, USA
- Leonard Jason, Prof (PhD), DePaul University, Chicago, USA
- Anthony Komaroff, Prof (MD), Brigham and Women's Hospital and Harvard Medical School, Boston, USA
- Eliana Lacerda, Prof (MD, PhD), London School of Hygiene and Tropical Medicine (LSHTM), UK
- W. Ian Lipkin, Prof (MD), Mailman School of Public Health and - Vagelos College of Physicians and Surgeons of Columbia University, New York, USA
- Sonya Marshall-Gradisnik, Prof (PhD), National Centre for Neuroimmunology and Emerging Diseases, Griffith University, Brisbane, Australia
- Josef Mautner, Dr, Helmholtz Munich, Germany
- Olav Mella, Prof (MD, PhD), University of Bergen, Norway
- Alain Moreau, Prof (PhD), University of Montreal, Canada
- Luis Nacul, Prof (MD, PhD), University of British Columbia, Vancouver, Canada
- Robert K. Naviaux, Prof (MD, PhD), University of Californa San Diego (UCSD) School of Medicine, San Diego, USA
- Peter Novak, Prof (MD), Brigham and Women's Hospital and Harvard Medical School, Boston, USA
- Michael Peluso, Prof (MD), MHS, University of California San Francisco (UCSF), USA
- Chris P. Ponting, Prof (PhD), University of Edinburgh, UK
- Resia Pretorius, Prof (PhD), Stellenbosch University, South Africa
- Christian Puta, Prof (PhD), Friedrich Schiller University Jena, Germany
- David Putrino, Prof (PhD), Icahn School of Medicine at Mount Sinai, New York, USA
- Herbert Renz-Polster, Dr (MD), currently unaffiliated, Germany
- Gabriela Riemekasten, Prof (MD), University Hospital Schleswig-Holstein (UKSH), Lübeck, Germany
- Peter Rowe, Prof (MD), Johns Hopkins University, Baltimore, USA
- Dominique Salmon, Prof (MD, PhD), Paris Descartes University, France
- Wakiro Sato, Dr (MD, PhD), National Center of Neurology and Psychiatry (NCNP), Tokyo, Japan
- Birgit Sawitzki, Prof, Charité – Universitätsmedizin Berlin, Germany
- Carmen Scheibenbogen, Prof (MD), Charité – Universitätsmedizin Berlin, Germany
- Elisabeth Schieffer, Dr (MD), University Hospital of Giessen and Marburg (UKGM), Marburg, Germany
- Claudia Schilling, Dr (MD), Central Institute of Mental Health (CIMH), Mannheim, Germany
- Georg Schlieper, Dr (MD), Dialysis Hannover - Center for Kidney, Hypertension and Metabolic Diseases, Germany
- Martina Seifert, Prof, Charité – Universitätsmedizin Berlin, Germany
- Nuno Sepúlveda, Prof (PhD), Warsaw University of Technology, Poland
- Yehuda Shoenfeld, Prof (MD), Tel Aviv University, Israel
- Fridbjörn Sigurdsson, Dr (MD), Landspitali - University Hospital, Reykjavik, Iceland
- Kristian Sommerfelt, Prof (MD), University of Bergen, Norway
- Franziska Sotzny, Dr, Charité – Universitätsmedizin Berlin, Germany
- Jürgen Steinacker, Prof (MD), Institute of Rehabilitation Medicine Research at Ulm University, Germany
- Michael Stingl, Dr (MD), Private Practice, Vienna, Austria
- David Systrom, Prof (MD), Brigham and Women's Hospital and Harvard Medical School, Boston, USA
- Karl Johan Tronstad, Prof (PhD), University of Bergen, Norway
- Derya Unutmaz, Prof (MD), The Jackson Laboratory for Genomic Medicine, USA
- Janneke van de Wijgert, Prof (MD), MPH, University Medical Center (UMC) Utrecht, Netherlands
- Johanna (Anske) van der Bom, Prof (MD, PhD), Leiden University Medical Center (UMC), Netherlands
- Maria J. G. T. Vehreschild, Prof (MD), Universitätsmedizin Frankfurt, Germany
- Cordula Warlitz, Dr (MD), Technical University of Munich (TUM) Hospital and Munich Schwabing Clinic, Germany
- Francisco Westermeier, Dr (PhD), FH JOANNEUM, Graz, Austria
- Klaus Wirth, Prof (MD, PhD), Mitodicure GmbH, Germany
- Rob Wust, Prof (PhD), Vrije Universiteit (VU) Amsterdam, Netherlands
- Takashi Yamamura, Prof (MD, PhD), National Center of Neurology and Psychiatry (NCNP), Tokyo, Japan
- Pawel Zalewski, Prof (PhD), Nicolaus Copernicus University, Torún, Poland